Adult-Onset Still's Disease: molecular pathophysiology and new therapeutic approaches

Key Findings

• ●NLRP3 inflammasome dysregulation central to pathogenesis
• ●NETs activate NLRP3 and inflammatory macrophages creating self-amplifying loop
• ●Comprehensive review of emerging therapies including JAK inhibitors

Referenced in (1 disease)